How Does Imipenem/Cilastatin Work? Mechanism of Action Explained in Plain English

Imipenem/Cilastatin (Primaxin) is a two-drug combination that works in a remarkably elegant way. One component kills bacteria directly. The other protects the first one from being destroyed by your own kidneys before it can do its job. Understanding how this drug works can help you appreciate why it's so powerful — and why it's reserved for the most serious infections.

The Problem Imipenem/Cilastatin Solves

When imipenem alone was first developed, researchers discovered a serious problem: the human kidney contains an enzyme called dehydropeptidase I (DHP-I) that breaks imipenem down into an inactive — and actually toxic — metabolite before the drug can reach its target. This meant that imipenem by itself was being destroyed by your own body before it could fight the infection, and the breakdown product caused kidney damage.

The solution was to combine imipenem with cilastatin — a drug that specifically blocks DHP-I. By blocking this enzyme, cilastatin allows imipenem to survive intact in the body and reach the site of infection, while also preventing the formation of the toxic metabolite. This is the fundamental reason the two drugs are always used together.

How Imipenem Kills Bacteria

Imipenem belongs to the beta-lactam family of antibiotics (the same family as penicillin and cephalosporins). Like all beta-lactams, imipenem kills bacteria by targeting their cell wall — the rigid outer structure that bacteria depend on to maintain their shape and survive. Here's the step-by-step:

1. Imipenem enters the bacterium: Imipenem is small enough to pass through tiny channels (porins) in the outer membrane of gram-negative bacteria, reaching the cell wall-building machinery inside.

2. It binds to Penicillin-Binding Proteins (PBPs): Imipenem attaches to PBPs — enzymes that bacteria use to cross-link strands of peptidoglycan (the structural material in bacterial cell walls). Imipenem has particularly high affinity for PBPs 1A, 1B, 2, 4, 5, and 6 — making it effective against a very broad range of bacteria.

3. Cell wall synthesis is blocked: With the PBPs inactivated, the bacterium can no longer build or repair its cell wall. Existing cell walls weaken and develop gaps.

4. The bacterium bursts and dies: Without a functional cell wall, bacteria cannot withstand the osmotic pressure difference between the inside of the cell and the outside environment. The bacterium swells, ruptures, and dies — a process called bacteriolysis.

Why Is Imipenem More Powerful Than Other Antibiotics?

Imipenem has two key advantages over most other beta-lactam antibiotics:

• Beta-lactamase resistance: Many bacteria defend themselves against beta-lactam antibiotics by producing enzymes called beta-lactamases that break down the drug before it can work. Imipenem is highly resistant to most beta-lactamases — including cephalosporinases and many extended-spectrum beta-lactamases (ESBLs) — making it effective against bacteria that have defeated other antibiotics.

• Binding to PBP-2: By binding to PBP-2 — a specific penicillin-binding protein — imipenem causes a particularly rapid form of bacterial lysis. This gives it a longer "post-antibiotic effect" (PAE) — bacteria continue to die even after drug levels fall below the minimum inhibitory concentration (MIC).

What Bacteria Is Imipenem/Cilastatin Effective Against?

Imipenem has one of the broadest antibacterial spectrums of any antibiotic:

• Gram-negative bacteria: Pseudomonas aeruginosa, Escherichia coli, Klebsiella, Enterobacter, Serratia, Proteus, Acinetobacter, Bacteroides fragilis

• Gram-positive bacteria: Streptococcus species, Enterococcus faecalis, Staphylococcus aureus (but NOT MRSA)

• Anaerobic bacteria: Bacteroides fragilis, Peptostreptococcus — bacteria that cause infections in oxygen-poor environments like the abdomen

Key resistances: Imipenem does NOT cover methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecium (VRE), and carbapenem-resistant organisms that produce metallo-beta-lactamases (MBLs) or carbapenemases (CRE with KPC, NDM, etc.).

How Does Cilastatin Protect Imipenem?

Cilastatin is a competitive inhibitor of dehydropeptidase I (DHP-I), an enzyme found in the brush border of the proximal renal tubules — the kidney cells that filter your blood. By blocking DHP-I, cilastatin:

• Prevents imipenem from being broken down in the kidney, allowing ~70% of the drug to be excreted unchanged in urine — providing effective antibiotic concentrations in the urinary tract

• Prevents formation of a toxic imipenem metabolite that would otherwise accumulate in kidney tissue and cause nephrotoxicity

• Both imipenem and cilastatin have approximately a 1-hour half-life and are both eliminated primarily through the kidneys — which is why dose adjustments are required in patients with renal impairment

The Time-Dependent Pharmacodynamics of Carbapenems

Imipenem works best when its concentration stays above the minimum inhibitory concentration (MIC) for the bacteria for as long as possible during the dosing interval — this is called "time-dependent killing." This is why Imipenem/Cilastatin is dosed every 6–8 hours rather than once or twice daily: maintaining consistent drug levels above the MIC is more important than achieving very high peak concentrations.

Why This Understanding Matters for Your Care

Understanding how Imipenem/Cilastatin works explains why missing doses is so harmful — even a few missed infusions can allow bacteria to regrow and potentially develop resistance. It also explains why kidney function monitoring is so critical — the drug levels and toxicity risk are directly tied to how well your kidneys are filtering. If you're struggling to get your medication due to the current shortage, medfinder can help locate pharmacies with current stock near you.